Johnson and Johnson's Animas unit received CE Mark approval for the first and only continuous glucose monitoring sensor-augmented insulin pump system with the Dexcom G4 sensor technology. The system, known as Animas Vibe, displays real-time glucose information and the sensor can be worn for up to seven days. And unlike other CGM-augmented pump systems, Animas Vibe displays glucose trends in color and is waterproof.
CGM-augmented systems like Animas Vibe give patients a more complete glucose picture versus fingersticks alone, according to an Animas statement.  

San Diego-based Dexcom develops and markets CGM systems for use at home and in healthcare settings. The partners originally announced a joint development agreement to integrate Dexcom's CGM technology into Animas insulin pumps back in January 2008.  They revised the agreement a year later, giving Animas exclusive rights to Dexcom CGM technology for integration into its insulin pumps outside the U.S.  Animas also retained the non-exclusive right to develop and market CGM-enabled ambulatory insulin pumps within the U.S. Animas Vibe is the first product offering under this agreement.  

The Egret Technologies-designed DexCom G4 Transmitter is an integral part of the Animas Vibe solution.